Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Share-based Compensation (2019 - 2025)

Outset Medical (OM) has disclosed Share-based Compensation for 7 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 17.84% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.6 million, a 46.8% decrease, with the full-year FY2025 number at $15.6 million, down 46.8% from a year prior.
  • Share-based Compensation was $4.1 million for Q4 2025 at Outset Medical, down from $5.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $10.9 million in Q3 2023 to a low of $2.9 million in Q3 2021.
  • A 5-year average of $6.4 million and a median of $6.1 million in 2021 define the central range for Share-based Compensation.
  • Biggest YoY gain for Share-based Compensation was 908.97% in 2021; the steepest drop was 79.41% in 2021.
  • Outset Medical's Share-based Compensation stood at $4.8 million in 2021, then skyrocketed by 53.44% to $7.4 million in 2022, then increased by 23.73% to $9.1 million in 2023, then crashed by 45.65% to $4.9 million in 2024, then decreased by 17.84% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Share-based Compensation are $4.1 million (Q4 2025), $5.1 million (Q3 2025), and $3.5 million (Q2 2025).